Paid Clinical Trials Charlotte

Discover 725 paid clinical trials in Charlotte, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 725

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Charlotte NC, North Charleston SC, Chamblee GA, Decatur GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Observational StudyCIED Infection Quality Initiative Demonstration Project

Recruiting

Sponsor:

Duke University

Location:

Charlotte NC, Greensboro NC, Chicago IL

Code:

NCT05471973

Conditions

Infections

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Multidisciplinary Team

Outreach Visits

Multifaceted Intervention

Measurement and Feedback

Virtual RealityImmersive Healing: The Therapeutic Potential of Virtual Reality

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Charlotte NC

Code:

NCT06077227

Conditions

Phantom Limb Pain (PLP)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

virtual reality therapy

matched control group

Upadacitinib vs. AdalimumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Charlotte NC, Marietta GA, Lexington KY, Hopkinsville KYshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

FrexalimabEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Charlotte NC, Winston-Salem NC, Greer SC, Raleigh NCshow 80 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

EtrasimodA Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Charlotte NC, Forest VA, Lynchburg VA, Atlanta GAshow 62 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Cullinan Therapeutics Inc.

Location:

Huntersville NC, Fairfax VA, Nashville TN, Birmingham ALshow 8 more

Code:

NCT05117476

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CLN-619

Pembrolizumab

DupilumabA Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Charlotte NC, Chapel Hill NC, Durham NC, Kinston NCshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

SelfWrapSAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Recruiting

Sponsor:

VenoStent

Location:

Charlotte NC, Spartanburg SC, Greenville SC, Florence SCshow 17 more

Code:

NCT06001827

Conditions

Chronic Kidney Diseases

End Stage Renal Disease

Arteriovenous Fistula

Hemodialysis Access Failure

ESRD

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SelfWrap Bioabsorbable Perivascular Wrap

Untreated AVF Control

Zongertinib vs. Standard TreatmentBeamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Rock Hill SC, Wilson NC, Fairfax VA, Huntsville ALshow 17 more

Code:

NCT06151574

Conditions

Lung Cancer, Non-squamous, Non-small Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zongertinib

pembrolizumab

cisplatin

carboplatin

pemetrexed

Deep Brain StimulationAutomated Deep Brain Stimulation Programming Using Functional Mapping

Recruiting

Sponsor:

Great Lakes NeuroTechnologies Inc.

Location:

Charlotte NC, Winston-Salem NC, Columbus OH

Code:

NCT02765282

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

Algorithm based programming using Kinesia-based assessment